Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryl Ho

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Expert Opinion on Investigational Drugs|July 4, 2009
EGFR-directed therapies to treat non-small-cell lung cancerCheryl Ho, Janessa Laskin
Cureus|June 2, 2022
Acute Onset of a Life-Threatening Skin Toxicity Due to Osimertinib: Severe Psoriasis Versus Toxic Epidermal NecrolysisRebekah Rittberg, Cheryl Ho, Ying Wang
Journal of Oncology Practice|February 18, 2016
Implementation of a Lung Cancer Nurse Navigator Enhances Patient Care and Delivery of Systemic Therapy at the British Columbia Cancer Agency, VancouverKelly Zibrik, Janessa Laskin, Cheryl Ho
JCO Oncology Practice|September 6, 2022
End-of-Life Health Resource Utilization for Limited English-Proficient Patients With Advanced Non-Small-Cell Lung CancerBonnie Leung, Selina K Wong, Cheryl Ho
Lung Cancer (Amsterdam, Netherlands)|January 21, 2015
Maintenance chemotherapy in advanced NSCLC: a population-based assessment of eligibilityKing Mong Tong, Janessa Laskin, Cheryl Ho
Journal of Neuro-Oncology|January 19, 2016
Radiographic patterns and survival of patients with early and late brain metastases in EGFR wild type and mutant non small cell lung cancerRen Yuan, Andrew Yamada, Britta Weber, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian EnvironmentCheryl Ho, Howard J Lim, Dean A Regier
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 20, 2019
Real-World Treatment of Stage III NSCLC: The Role of Trimodality Treatment in the Era of ImmunotherapySara Moore, Bonnie Leung, Jonn Wu, et al.
BMJ Case Reports|March 26, 2024
Treating anaplastic lymphoma kinase (ALK) fusion-driven metastatic non-small cell lung cancer (NSCLC) with alectinib through pregnancyFlorence Wu, Rebekah Rittberg, Kenneth Lim, et al.
American Journal of Clinical Oncology|January 5, 2019
Survival Implications of De Novo Versus Recurrent Metastatic Non-Small Cell Lung CancerSara Moore, Bonnie Leung, Jonn Wu, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Expert Opinion on Investigational Drugs|July 4, 2009
EGFR-directed therapies to treat non-small-cell lung cancerCheryl Ho, Janessa Laskin
Cureus|June 2, 2022
Acute Onset of a Life-Threatening Skin Toxicity Due to Osimertinib: Severe Psoriasis Versus Toxic Epidermal NecrolysisRebekah Rittberg, Cheryl Ho, Ying Wang
Journal of Oncology Practice|February 18, 2016
Implementation of a Lung Cancer Nurse Navigator Enhances Patient Care and Delivery of Systemic Therapy at the British Columbia Cancer Agency, VancouverKelly Zibrik, Janessa Laskin, Cheryl Ho
JCO Oncology Practice|September 6, 2022
End-of-Life Health Resource Utilization for Limited English-Proficient Patients With Advanced Non-Small-Cell Lung CancerBonnie Leung, Selina K Wong, Cheryl Ho
Lung Cancer (Amsterdam, Netherlands)|January 21, 2015
Maintenance chemotherapy in advanced NSCLC: a population-based assessment of eligibilityKing Mong Tong, Janessa Laskin, Cheryl Ho
Journal of Neuro-Oncology|January 19, 2016
Radiographic patterns and survival of patients with early and late brain metastases in EGFR wild type and mutant non small cell lung cancerRen Yuan, Andrew Yamada, Britta Weber, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian EnvironmentCheryl Ho, Howard J Lim, Dean A Regier
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 20, 2019
Real-World Treatment of Stage III NSCLC: The Role of Trimodality Treatment in the Era of ImmunotherapySara Moore, Bonnie Leung, Jonn Wu, et al.
BMJ Case Reports|March 26, 2024
Treating anaplastic lymphoma kinase (ALK) fusion-driven metastatic non-small cell lung cancer (NSCLC) with alectinib through pregnancyFlorence Wu, Rebekah Rittberg, Kenneth Lim, et al.
American Journal of Clinical Oncology|January 5, 2019
Survival Implications of De Novo Versus Recurrent Metastatic Non-Small Cell Lung CancerSara Moore, Bonnie Leung, Jonn Wu, et al.
Pageof 12